湖南省疼痛专科医联体成立

2017-12-21 华声在线 华声在线

​12月20日,湖南省疼痛专科医联体在湘雅三医院成立,并纳入国家级疼痛专科医联体共同发展,湖南省内100家医疗机构加盟。

12月20日上午,湖南省疼痛专科医联体在中南大学湘雅三医院成立,并纳入国家级疼痛专科医联体共同发展。中南大学湘雅医院、湘雅二医院、湘雅三医院、湖南省人民医院等省内100家医疗机构加盟。

安乡83岁娭毑胸痛

专家远程会诊

马娭毑今年83岁了,最近10多天胸口非常不适。家人将她送进常德安乡县人民医院就诊,医生初步诊断后,建议请更权威的医生为娭毑诊治。

经过老人家人同意,安乡县人民医院通过新湘雅的远程会诊平台,向湘雅三医院疼痛科主任黄东教授请求会诊。通过视频通话,黄东仔细诊治了马娭毑的病情,并给出了指导性的意见。现在,老人在安乡县人民医院进行治疗,病情有所好转。

“随着人口老龄化及生活方式的改变,慢性疼痛疾病已经成为了临床常见病和多发病,晚期癌症患者中癌痛的发病率高达70%-90%。基层患者为了解决一个疼痛问题,常常需要跑去不同医院、挂号不同科室、看到不同医生,给患者特别是老年患者带来非常大的不便。”黄东表示。目前,湖南省虽有近200家各级医疗机构注册了疼痛专科,疼痛执业医护人员近2000人,但疼痛专科人才仍缺乏,尤其是高级专科人才匮乏。

四大线上功能

助患者能远离疼痛

“医联体成立后,充分运用信息手段,线上实现四大功能:远程会诊,包括住院会诊和实时门诊;通过平台实现双向转诊,资料无缝对接;专家课堂,及时发布学科最新进展;学科交流,建立疼痛专科专家联盟,分层组织管理。”黄东介绍,线下还可根据医联体内医疗机构的实际需求,实现定点帮扶。同时,加大疼痛科普知识的宣传力度,让人民群众了解疼痛,重视疼痛,最后远离疼痛。

经过几年的努力,医联体将实现四个目标:一是探索全省疼痛专科医疗资源一体化的共享模式,明确各级医疗机构的功能定位,引导患者有序就医,有效实施分级诊疗;二是建立规范的临床医疗体系,推广疼痛专科诊疗规范,确保医疗安全;三是建立完备的省内疼痛专科医师培养体系,培养高水平的疼痛专科医师;四是加强省内各级医院疼痛学科的交流合作,建立疼痛专科医师交流平台,促进湖南省疼痛学科临床及科研发展。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1715335, encodeId=1ef71e1533543, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Sun Aug 12 06:44:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076800, encodeId=1e8520e68009c, content=<a href='/topic/show?id=3491664118c' target=_blank style='color:#2F92EE;'>#湖南省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66411, encryptionId=3491664118c, topicName=湖南省)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/F82CC4A89F97BD21D3DDB7AD5F2AD09D/100, createdBy=52952500022, createdName=ms6829001416292975, createdTime=Fri Jul 27 19:44:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335661, encodeId=fa401335661d9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 23 07:44:00 CST 2017, time=2017-12-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1715335, encodeId=1ef71e1533543, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Sun Aug 12 06:44:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076800, encodeId=1e8520e68009c, content=<a href='/topic/show?id=3491664118c' target=_blank style='color:#2F92EE;'>#湖南省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66411, encryptionId=3491664118c, topicName=湖南省)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/F82CC4A89F97BD21D3DDB7AD5F2AD09D/100, createdBy=52952500022, createdName=ms6829001416292975, createdTime=Fri Jul 27 19:44:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335661, encodeId=fa401335661d9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 23 07:44:00 CST 2017, time=2017-12-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1715335, encodeId=1ef71e1533543, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Sun Aug 12 06:44:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076800, encodeId=1e8520e68009c, content=<a href='/topic/show?id=3491664118c' target=_blank style='color:#2F92EE;'>#湖南省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66411, encryptionId=3491664118c, topicName=湖南省)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/F82CC4A89F97BD21D3DDB7AD5F2AD09D/100, createdBy=52952500022, createdName=ms6829001416292975, createdTime=Fri Jul 27 19:44:00 CST 2018, time=2018-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335661, encodeId=fa401335661d9, content=<a href='/topic/show?id=8d7a3525ed0' target=_blank style='color:#2F92EE;'>#医联体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35257, encryptionId=8d7a3525ed0, topicName=医联体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9de22500104, createdName=1249894fm73暂无昵称, createdTime=Sat Dec 23 07:44:00 CST 2017, time=2017-12-23, status=1, ipAttribution=)]